| Development of biomaterials for gene therapy S Han, RI Mahato, YK Sung, SW Kim Molecular Therapy 2 (4), 302-317, 2000 | 525 | 2000 |
| pH-sensitive cationic polymer gene delivery vehicle: N-Ac-poly (L-histidine)-graft-poly (L-lysine) comb shaped polymer JM Benns, JS Choi, RI Mahato, JS Park, SW Kim Bioconjugate chemistry 11 (5), 637-645, 2000 | 515 | 2000 |
| Emerging trends in oral delivery of peptide and protein drugs RI Mahato, AS Narang, L Thoma, DD Miller Critical Reviews™ in Therapeutic Drug Carrier Systems 20 (2&3), 2003 | 464 | 2003 |
| Cationic lipid-based gene delivery systems: pharmaceutical perspectives RI Mahato, A Rolland, E Tomlinson Pharmaceutical research 14, 853-859, 1997 | 342 | 1997 |
| Hydrophobization and bioconjugation for enhanced siRNA delivery and targeting D De Paula, MVLB Bentley, RI Mahato Rna 13 (4), 431-456, 2007 | 324 | 2007 |
| Novel branched poly (Ethylenimine)− cholesterol water-soluble lipopolymers for gene delivery D Wang, AS Narang, M Kotb, AO Gaber, DD Miller, SW Kim, RI Mahato Biomacromolecules 3 (6), 1197-1207, 2002 | 290 | 2002 |
| Biological and biomaterial approaches for improved islet transplantation AS Narang, RI Mahato Pharmacological reviews 58 (2), 194-243, 2006 | 289 | 2006 |
| Recent advances in hepatocellular carcinoma therapy R Dutta, RI Mahato Pharmacology & therapeutics 173, 106-117, 2017 | 282 | 2017 |
| Water-soluble lipopolymer for gene delivery S Han, RI Mahato, SW Kim Bioconjugate chemistry 12 (3), 337-345, 2001 | 264 | 2001 |
| Subcellular fate and off-target effects of siRNA, shRNA, and miRNA S Singh, AS Narang, RI Mahato Pharmaceutical research 28, 2996-3015, 2011 | 255 | 2011 |
| Pharmaceutical dosage forms and drug delivery: revised and expanded RI Mahato, AS Narang CRC Press, 2017 | 238 | 2017 |
| Extravasation of polymeric nanomedicines across tumor vasculature MK Danquah, XA Zhang, RI Mahato Advanced drug delivery reviews 63 (8), 623-639, 2011 | 225 | 2011 |
| Lipid and polymeric carrier-mediated nucleic acid delivery L Zhu, RI Mahato Expert opinion on drug delivery 7 (10), 1209-1226, 2010 | 223 | 2010 |
| Biodistribution and gene expression of lipid/plasmid complexes after systemic administration RI Mahato, K Anwer, F Tagliaferri, C Meaney, P Leonard, MS Wadhwa, ... Human gene therapy 9 (14), 2083-2099, 1998 | 200 | 1998 |
| Physicochemical and pharmacokinetic characteristics of plasmid DNA/cationic liposome complexes RI Mahato, K Kawabata, T Nomura, Y Takakura, M Hashida Journal of pharmaceutical sciences 84 (11), 1267-1271, 1995 | 198 | 1995 |
| Optimization of factors influencing the transfection efficiency of folate–PEG–folate-graft-polyethylenimine JM Benns, RI Mahato, SW Kim Journal of controlled release 79 (1-3), 255-269, 2002 | 196 | 2002 |
| Pharmaceutical perspectives of nonviral gene therapy RI Mahato, LC Smith, A Rolland Advances in genetics 41, 95-156, 1999 | 195 | 1999 |
| RNAi for treating hepatitis B viral infection Y Chen, G Cheng, RI Mahato Pharmaceutical research 25, 72-86, 2008 | 194 | 2008 |
| Mesenchymal stem cell and derived exosome as small RNA carrier and Immunomodulator to improve islet transplantation D Wen, Y Peng, D Liu, Y Weizmann, RI Mahato Journal of Controlled Release 238, 166-175, 2016 | 187 | 2016 |
| Nonviral Vectors for In Vivo Gene Delivery: Physicochemical and Pharmacokinetic Considerations RI Mahato, Y Takakura, M Hashida Critical Reviews™ in Therapeutic Drug Carrier Systems 14 (2), 1997 | 186 | 1997 |
Duane D. MillerUniversity of Tennessee College of Pharmacyuthsc.edu의 이메일 확인됨
